JAGSONPAL PHARMACEUTICALS
Back to Income Statement
|
JAGSONPAL PHARMACEUTICALS Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹269 Cr | ₹209 Cr | ₹237 Cr | ₹218 Cr | ₹188 Cr |
What is the latest Revenue of JAGSONPAL PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹269 Cr |
| Mar2024 | ₹209 Cr |
| Mar2023 | ₹237 Cr |
| Mar2022 | ₹218 Cr |
| Mar2021 | ₹188 Cr |
How is Revenue of JAGSONPAL PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹269 Cr | 28.76 | |
| Mar2024 | ₹209 Cr | -11.83 | |
| Mar2023 | ₹237 Cr | 8.79 | |
| Mar2022 | ₹218 Cr | 15.77 | |
| Mar2021 | ₹188 Cr | - | |
Compare Revenue of peers of JAGSONPAL PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JAGSONPAL PHARMACEUTICALS | ₹1,600.5 Cr | 3.7% | 8.3% | -1.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | NA | -3.9% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,321.0 Cr | 5% | 21.5% | 44.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,924.0 Cr | -2.1% | -0.2% | 34.3% | Stock Analytics | |
| CIPLA | ₹113,778.0 Cr | -2% | -2.5% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,025.9 Cr | 0.4% | 4.5% | -4.4% | Stock Analytics | |
JAGSONPAL PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JAGSONPAL PHARMACEUTICALS | 3.7% |
8.3% |
-1.3% |
| SENSEX | 0.7% |
0.8% |
-5.1% |
You may also like the below Video Courses